Juvena Therapeutics Secures $33.5 Million in Series B Financing

Fenwick & West and Wilson Sonsini Goodrich & Rosati have advised Juvena Therapeutics. Juvena Therapeutics, a clinical-stage biotechnology company, has raised $33.5 million in a Series…

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here
  Share:

Author: Leila Ahmed

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here